SCHEMBL17833144

SCHEMBL17833144

CNCCCNc1nc(-c2cccc(-c3cccc(Cl)c3)c2)nc2c(Cl)cccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 1/20 0.44
SYK P43405 2/20 0.42
PDE5A O76074 2/20 0.42
GAA P10253 1/20 0.41
NR4A2 P43354 1/20 0.41
ACP1 P24666 1/20 0.40
RAD52 P43351 1/20 0.40
MAPK1 P28482 2/20 0.40
POLB P06746 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
TGFBR1 P36897 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829888 0.87 POLB (0.55) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL17833146 0.83 USP1 (0.39) SMN1; SMN2KMT2AMEN1SYKNR4A2
SCHEMBL17833154 0.83 SYK (0.37) SMN1; SMN2KMT2ASYKGAANR4A2
SCHEMBL17833237 0.81 KMT2A (0.39) SMN1; SMN2KMT2AMEN1MAPTSYK
SCHEMBL17829856 0.80 RAD52 (0.62) KMT2AMEN1ACP1RAD52MAPK1
SCHEMBL17829887 0.78 POLB (0.54) KMT2AMEN1SYKNR4A2ACP1
SCHEMBL17830139 0.78 RAD52 (0.57) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL17833189 0.77 KMT2A (0.39) SMN1; SMN2KMT2AMEN1MAPTSYK
SCHEMBL17829588 0.76 RAD52 (0.57) KMT2AACP1RAD52MAPK1POLB
SCHEMBL17829890 0.75 RAD52 (0.53) KMT2ASYKNR4A2ACP1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016094730-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS SYNERECA PHARMACEUTICALS, INC. (US) 2016-06-16 WO disclosed